Events & News
Ajinomoto Cambrooke events and news.
-
February 27, 2021
Ajinomoto Cambrooke, Inc. sponsored the premiere of the award-winning documentary, "So What Can You Eat?", on February 27, 2021.
-
January 8, 2021
Ajinomoto Cambrooke, Inc. hosted an online seminar, on December 19, 2020, for our distribution partner in China, as well as for local PKU patients. The focus was to provide the benefits of Glycomacropeptide (GMP) and our products made from it.
Since the acquisition by Ajinomoto, Cambrooke has been exploring an opportunity to support PKU patients in China and currently supplies 780g BetterMilk in Orange Creme and Strawberry Creme flavors. BetterMilk was originally launched, in the US, in 2010 and its clinical benefits and great taste are loved by patients in nearly 20 countries today.
For access to BetterMilk in China, please contact our distribution partner, Synutra group (Shengtong Nutrition), and its local partner, QianlinBaby. Ms. Zhao who is the president of the China PKU union was also invited to the seminar. She visited Cambrooke in 2017 and knows our products very well. She is very excited that Cambrooke products are now available to better support patients in China and will be supporting Chinese patients in understanding the benefits of BetterMilk products.
味之素 Cambrooke 公司于2020年12月19日为我们在中国的分销合作伙伴以及患者举办了一次在线研讨会。重点介绍了糖巨肽（GMP）和BetterMilk产品的益处。
自从被味之素公司收购以来，Cambrooke公司一直在寻找支持中国PKU患者的机会，目前对中国供应780g香橙味和草莓味的BetterMilk产品。BetterMilk最初于2010年在美国上市，它的临床功效和良好的口感如今受到近20个国家患者的信赖和喜爱。
对供应在中国销售的Better Milk，请咨询我们的分销合作伙伴圣元集团（圣桐营养）及其当地合作伙伴千林宝贝（QianlinBaby）。本次研讨会邀请到中国PKU联盟赵宁会长参加。她曾于2017年访问过Cambrooke公司，非常了解我们的产品。赵宁会长对Cambrooke产品现在可以更好地支持中国患者感到高兴，并愿意帮助中国PKU患者了解Cambrooke产品。
-
December 21, 2020
Press Release: Ajinomoto Cambrooke, Inc. Continues to Expand Worldwide with the Acquisition of Nualtra Ltd. read article
-
July 8, 2020
Press Release: Cambrooke Introduces Advanced New Hypoallergenic Amino Acid-based Formulas: EquaCare Jr.™ and Essential Care Jr.™. read article
-
April 2, 2019
Press Release: Cambrooke Therapeutics, Inc. announced it has changed its corporate name to Ajinomoto Cambrooke, Inc. effective April 1, 2019. read article
-
February 15, 2019
Press Release: Cambrooke Therapeutics and Trovita Health Science Announce Strategic Alliance for ENU® Nutrition. read article
-
November 1, 2018
Press Release: Cambrooke announces its metabolic liquids and KetoVie formulas are now OU-D kosher certified. read article
-
April 4, 2018
Press Release: Cambrooke announces its latest breakthrough in Phenylketonuria (PKU) medical foods with the purest glycomacropeptide (GMP) based protein: Glytactin BUILD 20/20™ and Glytactin RTD Lite 15. read article
-
November 13, 2017
Press Release: Cycle Pharmaceuticals Launches Free Trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ Dietary Needs. read more
-
November 10, 2017
Press Release: Cambrooke announced it has been acquired by Ajinomoto Co. Inc. (Ajinomoto), a worldwide leader in amino acids, pharmaceuticals, high-quality seasonings, processed foods, beverages, and specialty chemicals, through its subsidiary Ajinomoto North America, Inc. read article
-
April 25, 2017
Press Release: Cambrooke announces the launch of Tylactin™ COMPLETE Bars, a nutritionally complete medical food, available in a convenient portable format, for the dietary management of Tyrosinemia (TYR). read article
-
November 28, 2016
Press Release: Cambrooke announce the launch of the long awaited baking mix, KetoVie Café Kwik Mix 4.5:1, to its popular line of a ketogenic foods. read article
-
November 7, 2016
Press Release: Cambrooke announces the introduction of two new low protein meat alternatives: Burger Patty Mix and Chicken Patty Mix. read article
-
September 27, 2016
Press Release: Cambrooke announces the launch of Tylactin™ RESTORE Powder, a medical food hydration beverage, available in convenient portable single-serve stick-packs for the dietary management of Tyrosinemia (TYR). read article
-
September 22, 2016
Press Release: Cambrooke announces the introduction of Glytactin™ BUILD, a unique medical food for the dietary management of Phenylketonuria (PKU). read article
-
September 20, 2016
Press Release: Cambrooke is pleased to announce a new and improved Glytactin™ Complete Bar, a medical food for the dietary management of Phenylketonuria (PKU). read article
-
September 9, 2016
Press Release: Cambrooke announces the introduction of Glytactin RESTORE Powder™ and Glytactin RESTORE Lite Powder™, two medical food hydration beverages offered in convenient, portable, single-serve, stick-packs for the dietary management of Phenylketonuria (PKU). read article
-
August 11, 2016
Press Release: Cambrooke announces the introduction of two new, low protein foods: Original and Savory Cracker Thins, as well as Frosted Flakes and CoCo Roos cereals. read article
-
July 13, 2016
New PKU Evidence Published Today!
Read the details of this key study using Cambrooke's Glytactin™, made with GMP, a natural whole protein, for the nutritional management of PKU. Study published in the American Journal of Clinical Nutrition: "Glycomacropeptide for the nutritional management of phenylketonuria: a randomized, controlled, crossover trial." read article
-
July 13, 2016
Press Release: A new whey to manage PKU. "Food products made from a specific protein found in whey can safely be part of a more palatable diet for individuals diagnosed with phenylketonuria (PKU), according to a new clinical trial led by researchers at the University of Wisconsin—Madison and Boston Children’s Hospital. ‘Our findings could also lead to increased insurance coverage for ‘medical foods’ that individuals with PKU need to lead healthy lives,’ says Denise Ney, the lead author of the study." read more
-
May 10, 2016
KetoVie Café Pizza Petites 3:1 added to the Cambrooke Therapeutics Line of ketogenic diet-friendly foods. read more
-
Aril 12, 2016
Cambrooke expands its KetoVie Café food line with the launch of KetoVie Café Donut Delights - Cinnamon 3:1. read more
-
April 11, 2016
Cambrooke announces the closing of the Series C investment round, led by Seventure Partners (Paris, France), an asset manager, investing out of its latest healthcare and nutrition focused Health For Life Capital™ vehicle. read more
-
April 1, 2016
Cambrooke announces the KetoVie Peptide, a groundbreaking hydrolyzed protein-based ketogenic formula for children with intractable epilepsy. read more
-
February 11, 2016
Cambrooke announces the launch of their new KetoVie.com website, aimed to help families reclaim as normal a life as possible while on a ketogenic diet for the dietary management of epilepsy. read more
-
August 26, 2015
Cambrooke announces the introduction of an advanced family of amino acid based medical foods the dietary management of several disorders of amino acid metabolism. read more
-
June 22, 2015
Cambrooke announces the introduction of BetterMilk Lite™, an advanced, lower calorie medical food. read more
-
June 16, 2015
Cambrooke announces launch of low protein Pea-Not Butter and Tortilla Chips. read more
-
April 23, 2015
Cambrooke Announces Launch of KetoVie Café™ - a family of low-carbohydrate convenient ketogenic friendly foods which may be incorporated into the daily meals and snacks of individuals following the spectrum of ketogenic diets. read more
-
March 26, 2015
-
March 24, 2015
Cambrooke Announces Launch of KetoVie™ - an Advanced Ketogenic Diet Therapy Medical Food.
KetoVie 4:1 is a Medical Food for the dietary management of intractable epilepsy and other disorders requiring ketogenic therapy. The advanced KetoVie 4:1 is nutritionally complete and addresses the most common nutritional shortcomings associated with the ketogenic diet. read more
-
January 15, 2015
Cambrooke Therapeutics celebrates 15 years.
Cambrooke opened its doors in January 2000. Founder’s David and Lynn Paolella named Cambrooke after their two children Cameron and Brooke, who both have PKU. Cambrooke provides more than 100 medical foods and medical formulas for people with PKU and other genetic metabolic disorders. David who sits on the Board of Directors and Lynn working in Product Development are both passionately involved nationally and internationally helping people with these disorders.
-
February 24, 2014
Worcester Business Journal article. read more
-
February 20, 2014
Boston Globe article "Family company widens options for people with genetic disorder" featuring Cambrooke and company cofounder Lynn Paolella. read more
-
December 4, 2013
Cambrooke Therapeutics changes its name to reflect its broader focus on developing and offering therapeutic nutrition products for people with highly specialized, medically supervised diets. read more
